The results suggest that CD44 is useful for assessing lymph node metastases and stratifying the degree of tumor differentiation, while ALDH1 may serve as a strong indicator of malignant transformation risk in OPMD. This evidence concerns the gene ALDH1A1 and oculopharyngeal muscular dystrophy.